Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 4

Featuring perspectives from Dr Adam Brufsky, including the following topics: Introduction (0:00) HER2 in the Real World (1:16) Case: A woman in her early 60s with triple-positive metastatic breast cancer (mBC) — Joseph Martins, MD (4:32) Case: A woman in her late 60s with ER/PR-negative, HER2-positive breast cancer and brain metastases — Rohit Gosain, MD (19:41) Case: A woman in her late 60s with ER/PR-positive, HER2-positive mBC with recurrence in the brain — Alan B Astrow, MD (24:49) Journal Club with Dr Brufsky — Part 1 (28:42) Case: A woman in her early 80s with ER-positive, PR-negative, HER2-positive localized breast cancer and treated chronic lymphocytic leukemia — Shachar Peles, MD (31:45) Case: A woman in her late 50s with ER-negative, HER2-positive mBC with a PIK3CA mutation — Sunil Gandhi, MD (45:47) Case: A woman in her early 50s with ER/PR-positive, HER2-positive infiltrating lobular breast cancer — Ferdy Santiago, MD (52:08) Journal Club with Dr Brufsky — Part 2 (55:18) CME information and select publications